Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01016808 · ClinicalTrials.gov registry record · Phase 3
Comparison of the Efficacy and Safety of Q8003 Versus Its Individual Components in Bunionectomy Patients
A Phase 3 study, sponsored by QRxPharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 522
- Enrollment target
NCT01016808: Completed Phase 3 study, sponsored by QRxPharma.
NCT01016808 is a Phase 3 study that has completed, run by QRxPharma. The registered enrollment target is 522 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (32% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01016808, a Phase 3 study, has completed, sponsored by QRxPharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 522 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, multicenter, fixed dose factorial study of Q8003 12 mg/8 mg versus its individual morphine sulfate and oxycodone hydrochloride components for the management of acute moderate to severe postoperative pain following bunionectomy surgery.
Interventions
- DRUG Morphine sulfate
- DRUG Oxycodone HCl
- DRUG Q8003
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 522 participants |
| Start Date | 2009-12 |
| Est. Completion | 2010-03 |
| Phase | Phase 3 |
What the finished NCT01016808 record still lists
NCT01016808 is an interventional study that assigns participants to a tested intervention. The registered 522 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (32% lower).
The record links to 0 conditions, and to 3 interventions - of which Morphine sulfate is the first listed.
NCT01016808 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01016808 about?
NCT01016808 is a clinical study titled "Comparison of the Efficacy and Safety of Q8003 Versus Its Individual Components in Bunionectomy Patients". This is a randomized, double-blind, multicenter, fixed dose factorial study of Q8003 12 mg/8 mg versus its individual morphine sulfate and oxycodone hydrochloride components for the management of acute moderate to severe postoperative pain following bunionectomy surgery.
What is the current status of trial NCT01016808?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 522 participants. The study started on 2009-12. Estimated completion is 2010-03.
What interventions are being tested in trial NCT01016808?
The interventions under investigation include: Morphine sulfate (DRUG), Oxycodone HCl (DRUG), Q8003 (DRUG).
Who is sponsoring clinical trial NCT01016808?
This trial is sponsored by QRxPharma, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01016808's enrollment target sits among peer trials
522 716th of 2000 higher than 1,284 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06835686 · 522 participants · NA
Collaborative Multi-level Obesity Intervention Engaging Underserved Communities Trial
- NCT06894212 · 522 participants · Phase 3
A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
- NCT03526835 · 523 participants · Phase 1
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- NCT04580134 · 524 participants · Phase 4
CLOZAPINE Response in Biotype-1
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia